Author

Haruki Jimbo

Kobe UniversityORCID 0000-0003-4411-7561Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Ai YoshiokaiD· 1 shared Claire Yik-Lok ChungiD· 1 shared Hideki TanizawaiD· 1 shared Ken-ichi NomaiD· 1 shared Shinya HashimotoiD· 1 shared Shinya OhtaiD· 1 shared Takeshi FukumotoiD· 1 shared Xuebing WangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ai YoshiokaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyJournal of Investigative DermatologyPeer-reviewedApr 1, 2024

Chemo-senolytic therapeutic potential against angiosarcoma

Xuebing Wang, Claire Yik-Lok Chung, Ai Yoshioka…·Ken-ichi Noma

This study explores combining cisplatin and the senolytic agent ABT-263 to treat angiosarcoma, showing that low-dose cisplatin induces senescence, which is then eliminated by ABT-263, reducing chemotherapy side effects.

6 citations

humanexperimental assay

𝕏 PostBluesky